- Home
- OFIX vs EBS Comparison
OFIX vs EBS Comparison
Compare OFIX & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OFIX | EBS |
|---|---|---|
| Founded | 1987 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 622.1M | 663.3M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | OFIX | EBS |
|---|---|---|
| Price | $13.38 | $12.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $21.50 | $15.00 |
| AVG Volume (30 Days) | 205.9K | ★ 973.1K |
| Earning Date | 02-24-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $818,058,000.00 | $788,900,000.00 |
| Revenue This Year | $3.97 | N/A |
| Revenue Next Year | $5.84 | $15.21 |
| P/E Ratio | ★ N/A | $8.95 |
| Revenue Growth | ★ 4.31 | N/A |
| 52 Week Low | $10.24 | $4.02 |
| 52 Week High | $20.48 | $14.06 |
Technical Indicators
Market Signals| Indicator | OFIX | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 31.12 | 53.36 |
| Support Level | $13.30 | $10.60 |
| Resistance Level | $14.23 | $12.58 |
| Average True Range (ATR) | 0.56 | 0.79 |
| MACD | -0.19 | -0.12 |
| Stochastic Oscillator | 5.29 | 51.16 |
Price Performance
Historical ComparisonAbout OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.